Skip to main content
Top
Published in: Breast Cancer 5/2015

01-09-2015 | Original Article

Radiation exposure during sentinel lymph node biopsy for breast cancer: effect on pregnant female physicians

Authors: Fuyo Kimura, Mana Yoshimura, Kiyoshi Koizumi, Hiroshi Kaise, Kimito Yamada, Ai Ueda, Norio Kohno

Published in: Breast Cancer | Issue 5/2015

Login to get access

Abstract

Background

The radionuclide (RN) method employed for sentinel lymph node biopsy is generally safe for adult medical care workers. However, the number of pregnant medical care workers who attend surgery has recently been increasing, along with the increasing number of female surgeons. In particular, female surgeons are concerned about the position of a surgeon’s lower abdominal region being close to the RN injection site. We measured the exposure dose of the lower abdominal region in medical care workers and investigated the possible exposure effect on fetuses.

Methods

A dose of 99mTc-phytic acid (37 MBq) was subcutaneously injected into the areola of the nipple of patients. Scintigraphy and surgery were performed after 1 and 4 h, respectively. At the time of the local injection, a personal dosimeter measured the exposure dose in the surgeon, first and second assistants, anesthesiologist, and scrub nurse.

Results

The median exposure doses were 3, 1, 1, 0, and 0 μSv in the surgeon, first and second assistants, anesthesiologist, and scrub nurse, respectively. Protective clothing reduced the mean exposure dose by 66 %.

Conclusions

In surgeons, the exposure dose from daily life activities (1 mSv/year) corresponds to the dose received after performing 333 surgeries (using 3 μSv as the median). However, the maximum value measured was 24 μSv; at this value, the total exposure dose exceeds 1 mSV in the 42nd surgery. Medical care workers can further reduce their exposure dose by paying attention to the surgical procedure and to their posture and position.
Literature
1.
go back to reference Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.PubMedCrossRef Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.PubMedCrossRef
2.
go back to reference Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999;126:714–20.PubMedCrossRef Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999;126:714–20.PubMedCrossRef
3.
go back to reference Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat. 2000;63:31–40.PubMedCrossRef Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat. 2000;63:31–40.PubMedCrossRef
4.
go back to reference McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noves RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–6.PubMed McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noves RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–6.PubMed
5.
go back to reference Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localization and false negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–8.PubMedCrossRef Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localization and false negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–8.PubMedCrossRef
6.
go back to reference Spanheimer PM, Graham MM, Sugg SL, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16:1143–7.PubMedCrossRef Spanheimer PM, Graham MM, Sugg SL, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16:1143–7.PubMedCrossRef
7.
go back to reference Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuere HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–5.PubMedCrossRef Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuere HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–5.PubMedCrossRef
8.
go back to reference Pandit-Taskar N, Dauer LT, Montgomery L, St Germain J, Zanzonico PB, Divgi CR. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med. 2006;47:1202–8.PubMed Pandit-Taskar N, Dauer LT, Montgomery L, St Germain J, Zanzonico PB, Divgi CR. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med. 2006;47:1202–8.PubMed
9.
go back to reference Japanese Society of Nuclear Medicine. The guidelines in the proper use of radiopharmaceuticals. C. Sentinel node detection and lymphoscintigraphy. (Japanese Society of Nuclear Medicine web site) 77–94. 2001. http://www.jsnm.org/guideline/20040714. Accessed Feb 1 2013. Japanese Society of Nuclear Medicine. The guidelines in the proper use of radiopharmaceuticals. C. Sentinel node detection and lymphoscintigraphy. (Japanese Society of Nuclear Medicine web site) 77–94. 2001. http://​www.​jsnm.​org/​guideline/​20040714. Accessed Feb 1 2013.
10.
go back to reference Stratmann SL, McCarty TM, Kuhn JA. Radiation safety with breast sentinel node biopsy. Am J Surg. 1999;178:454–7.PubMedCrossRef Stratmann SL, McCarty TM, Kuhn JA. Radiation safety with breast sentinel node biopsy. Am J Surg. 1999;178:454–7.PubMedCrossRef
11.
go back to reference Stenerlow B, Karlsson KH, Cooper B, Rydberg B. Measurement of prompt DNA double-strand breaks in mammalian cells without including heat-labile sites: results for cells deficient in nonhomologous end joining. Radiat Res. 2003;159:502–10.PubMedCrossRef Stenerlow B, Karlsson KH, Cooper B, Rydberg B. Measurement of prompt DNA double-strand breaks in mammalian cells without including heat-labile sites: results for cells deficient in nonhomologous end joining. Radiat Res. 2003;159:502–10.PubMedCrossRef
12.
go back to reference Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6:520–8.PubMedCrossRef Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6:520–8.PubMedCrossRef
13.
go back to reference International Commission on Radiological Protection (ICRP). Pregnancy and medical radiation. ICRP publication no. 84. Ann ICRP. 2000;30:1–43. International Commission on Radiological Protection (ICRP). Pregnancy and medical radiation. ICRP publication no. 84. Ann ICRP. 2000;30:1–43.
14.
go back to reference Japan Industrial Safety and Health Association. A commentary of the ordinance on prevention of ionizing radiation hazards. Tokyo: Sun graphics Ltd; 2011. p. 35–56. Japan Industrial Safety and Health Association. A commentary of the ordinance on prevention of ionizing radiation hazards. Tokyo: Sun graphics Ltd; 2011. p. 35–56.
15.
go back to reference Fukuda A, Koshiba K, Yamaguchi I, Takahashi M, Kitabayashi K, Matsubara K, et al. Shielding effect of clinical X-ray protector and lead glass against annihilation radiation and gamma rays of 99mTC (in Japanese with English abstract). Nihon Hoshasen Gijutu Gakkai Zasshi. 2004;60:1723–9. Fukuda A, Koshiba K, Yamaguchi I, Takahashi M, Kitabayashi K, Matsubara K, et al. Shielding effect of clinical X-ray protector and lead glass against annihilation radiation and gamma rays of 99mTC (in Japanese with English abstract). Nihon Hoshasen Gijutu Gakkai Zasshi. 2004;60:1723–9.
Metadata
Title
Radiation exposure during sentinel lymph node biopsy for breast cancer: effect on pregnant female physicians
Authors
Fuyo Kimura
Mana Yoshimura
Kiyoshi Koizumi
Hiroshi Kaise
Kimito Yamada
Ai Ueda
Norio Kohno
Publication date
01-09-2015
Publisher
Springer Japan
Published in
Breast Cancer / Issue 5/2015
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-013-0504-0

Other articles of this Issue 5/2015

Breast Cancer 5/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine